Mitchell Shawnte (CIK 0001749432)

Latest company ownership

Role: SVP, GC and Corporate Affairs
Shares held
134,800
Last filed at
Mar 19, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 1, 2019 Mar 4, 2019 Aptevo Therapeutics Inc. SVP, GC and Corporate Affairs Sell 27.5 -2,012 -2.44% $3.2K
Aug 9, 2018 Aug 13, 2018 Aptevo Therapeutics Inc. SVP, GC and Corporate Affairs Sell 37.5 -383 -0.50% $1.7K